To further investigate the effects of CRT on surface PD-L1 in vivo, we retrospectively selected patients treated with neoadjuvant CROSS CRT followed by esophagectomy at a single tertiary cancer center over a 10 year time period (n=19). This evidence concerns the gene CD274 and cancer.